Skip to main content

Table 1 Overall characteristic of ASO patients and healthy donors included in study

From: MicroRNA profile of circulating CD4+ T cells in aged patients with atherosclerosis obliterans

Variable ASO group Healthy group P value
Gender    
 Male 26 16 P > 0.05
 Female 7 7
Age (years old)    
 35–55 3 13 P < 0.05
 56–75 21 8
 76–95 9 3
Fontaine classification    
 I 0 0  
 II 10 0  
 III 7 0  
 IV 16 0  
Surgery 0 0  
Smoking 10 0 P < 0.01
Hepatic Lipidosis 11 0  
Hypertension 18 0 P < 0.01
Hyperlipidemia 0 0  
Diabetes 3 0 P > 0.05
Renal diseases 0 0  
Autoimmune diseases 0 0  
Infective diseases 0 0  
Immunosuppressive treatment 0 0  
Lipid-lowering agents 0 0  
Tumors 0 0  
Retinal arteriosclerosis 33 0  
FMD    
 < 10% 33 0  
 ≥ 10%, ≤ 20% 0 24  
Blood glucose (mmol/L)    
 ≤ 6.0 33 24 P > 0.05
 > 6.0 0 0
WBC (× 109)    
 ≤ 4.0 0 0 P > 0.05
 > 4.0, ≤ 10.0 33 24
 > 10.0 0 0
Lymphocytes (× 109)    
  ≤ 1.0 0 0 P < 0.05
 > 1.0, ≤ 3.3 33 24
 > 3.3 0 0
  1. ASO: atherosclerosis obliterans; FMD: Flow-mediated vasodilation; WBC: White blood cells